A Study to Evaluate the Safety,PK and PD of APG-2575 in Patients With Hematologic Malignancies
A Study to Evaluate the Safety,PK and PD of APG-2575 in Patients With Hematologic Malignancies
Active, not recruiting · NCT03913949 · Registry updated 2026-05-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety,PK and PD of APG-2575 in Patients With Hematologic Malignancies | B-cell chronic lymphocytic leukemia, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, neoplasm, non-Hodgkin lymphoma | Active, not recruiting | Phase 1 | 2026-05-01 | NCT03913949 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ascentage Pharma Group Inc. | 30 |
| Suzhou Yasheng Pharmaceutical Co., Ltd. | 8 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Anhui Procincial hospital | Hefei | China | 1 |
| Blood Diseases Hospital Chinese Academy of Medical Sciences | Tianjin | China | 2 |
| Henan Provincial Oncology Hospital | Zhengzhou | China | 3 |
| The First Affiliated Hospital, Zhejiang University School of Medicin | Hangzhou | China | 1 |
| Zhongnan Hospital of Wuhan University | Wuhan | China | 34 |